Amano Corporation (TYO:6436)

Theseus Pharmaceuticals Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	55,410	66,466	62,577	62,399	60,337	56,432
Short-Term Investments	1,340	1,355	2,725	3,357	3,219	2,556
Cash & Short-Term Investments	56,750	67,821	65,302	65,756	63,556	58,988
Cash Growth	-7.89%	3.86%	-0.69%	3.46%	7.74%	4.01%
Receivables	32,887	40,187	35,645	30,467	27,527	26,776
Inventory	16,574	15,630	15,189	13,410	9,987	8,852
Other Current Assets	8,638	4,481	4,756	4,116	4,467	3,984
Total Current Assets	114,849	128,119	120,892	113,749	105,537	98,600
Property, Plant & Equipment	30,687	32,368	31,096	29,135	25,780	25,592
Long-Term Investments	21,955	22,094	21,782	18,934	18,271	15,856
Goodwill	1,303	1,468	1,884	1,214	1,417	1,612
Other Intangible Assets	8,053	8,041	6,858	5,626	5,832	6,495
Long-Term Deferred Tax Assets	2,026	2,246	2,071	2,591	2,505	2,403
Other Long-Term Assets	1	2	2	1	-	1
Total Assets	178,874	194,338	184,585	171,250	159,342	150,559
Accounts Payable	8,343	9,390	13,512	12,422	11,272	10,444
Accrued Expenses	1,614	3,730	3,173	2,896	2,697	2,469
Short-Term Debt	659	871	94	266	367	520
Current Portion of Leases	5,895	6,399	5,407	4,150	3,610	2,843
Current Income Taxes Payable	2,846	5,616	4,100	3,523	3,426	1,445
Other Current Liabilities	24,654	20,887	19,003	15,256	13,453	13,088
Total Current Liabilities	44,011	46,893	45,289	38,513	34,825	30,809
Long-Term Leases	7,452	8,057	8,356	7,791	4,994	4,856
Long-Term Deferred Tax Liabilities	21	31	23	16	12	128
Other Long-Term Liabilities	1,573	1,313	1,094	1,012	863	873
Total Liabilities	54,473	57,777	56,483	49,613	43,071	38,974
Common Stock	18,239	18,239	18,239	18,239	18,239	18,239
Additional Paid-In Capital	19,293	19,293	19,293	19,293	19,293	19,293
Retained Earnings	94,202	101,851	94,510	90,133	86,244	81,749
Treasury Stock	-16,780	-14,424	-12,668	-9,019	-6,546	-4,443
Comprehensive Income & Other	8,977	10,969	8,226	2,109	-1,711	-3,986
Total Common Equity	123,931	135,928	127,600	120,755	115,519	110,852
Minority Interest	470	633	502	882	752	733
Shareholders' Equity	124,401	136,561	128,102	121,637	116,271	111,585
Total Liabilities & Equity	178,874	194,338	184,585	171,250	159,342	150,559
Total Debt	14,006	15,327	13,857	12,207	8,971	8,219
Net Cash (Debt)	42,744	52,494	51,445	53,549	54,585	50,769
Net Cash Growth	-8.94%	2.04%	-3.93%	-1.90%	7.52%	3.82%
Net Cash Per Share	600.33	735.83	714.32	732.50	737.36	680.00
Filing Date Shares Outstanding	70.73	71.28	71.52	72.6	73.56	74.25
Total Common Shares Outstanding	70.73	71.28	71.71	72.9	73.89	74.62
Working Capital	70,838	81,226	75,603	75,236	70,712	67,791
Book Value Per Share	1752.06	1906.83	1779.41	1656.41	1563.31	1485.47
Tangible Book Value	114,575	126,419	118,858	113,915	108,270	102,745
Tangible Book Value Per Share	1619.79	1773.44	1657.50	1562.59	1465.21	1376.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.